{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:25:02Z","timestamp":1772166302010,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-025-03752-9","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:27:30Z","timestamp":1766413650000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multimodality approach for locally advanced lung cancer: when is surgery most beneficial?"],"prefix":"10.1186","volume":"20","author":[{"given":"Riad Amin","family":"Abdeljalil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahed","family":"Al-odwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2295-1945","authenticated-orcid":false,"given":"Sakhr","family":"Alshwayyat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen Osama","family":"Nemrawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taher Abu","family":"Hejleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Alrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameer","family":"Yaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam Abu","family":"Jazar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamal","family":"Khader","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoud","family":"Al-Nsour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussam","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riad Abdel","family":"Jalil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"3752_CR1","doi-asserted-by":"crossref","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3).","DOI":"10.3322\/caac.21660"},{"key":"3752_CR2","doi-asserted-by":"crossref","unstructured":"Meldgaard P, Kristensen M, Conte S, Kaae Andersen K, Jovanovic A, Meldgaard E. Improved overall survival for stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018\u2013a cohort study in Denmark. Acta Oncol (Madr). 2023;62(12).","DOI":"10.1080\/0284186X.2023.2254474"},{"key":"3752_CR3","doi-asserted-by":"crossref","unstructured":"Auliac JB, Greillier L, Martin E, Falcoz PE, Boisselier P, Ano S et al. Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French National study. Respir Med Res. 2024;85.","DOI":"10.1016\/j.resmer.2024.101087"},{"key":"3752_CR4","doi-asserted-by":"crossref","unstructured":"Murakami H, Horinouchi H, Harada H, Sobue T, Kato T, Atagi S et al. Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: expanded cohort of the SOLUTION study. Lung Cancer. 2022;165.","DOI":"10.1016\/j.lungcan.2021.12.005"},{"key":"3752_CR5","doi-asserted-by":"crossref","unstructured":"Luo W, Zhong R, Yang M, Zhou Q. Interpretation of expert consensus on treatment for stage III non-small cell lung cancer. Med Adv. 2023;1(1).","DOI":"10.1002\/med4.5"},{"key":"3752_CR6","doi-asserted-by":"crossref","unstructured":"Luna JM, Barsky AR, Shinohara RT, Roshkovan L, Hershman M, Dreyfuss AD et al. Radiomic phenotypes for improving early prediction of survival in stage III Non-Small cell lung cancer adenocarcinoma after chemoradiation. Cancers (Basel). 2022;14(3).","DOI":"10.3390\/cancers14030700"},{"key":"3752_CR7","doi-asserted-by":"crossref","unstructured":"Wang T, Li L, Huang L, Wei Liu J, Xing Zhu D, Si Dong J et al. A phase II study of Tislelizumab (TIS) and chemotherapy as neoadjuvant therapy for potentially resectable stage IIIA\/IIIB non-small cell lung cancer (NSCLC). 2024.","DOI":"10.1200\/JCO.2024.42.16_suppl.8024"},{"key":"3752_CR8","doi-asserted-by":"crossref","unstructured":"Qi Y, Sun Y, Zhu H, Guo H. Efficacy and surgical safety of sequential surgical resection after neoadjuvant chemoimmunotherapy for unresectable stage III NSCLC. 2024.","DOI":"10.1200\/JCO.2024.42.16_suppl.8073"},{"key":"3752_CR9","doi-asserted-by":"crossref","unstructured":"Passaro A, Mok TSK, Attili I, Wu YL, Tsuboi M, De Marinis F et al. Adjuvant treatments for surgically resected Non-Small cell lung cancer harboring EGFR mutations: A review. 9, JAMA Oncol. 2023.","DOI":"10.1001\/jamaoncol.2023.0459"},{"key":"3752_CR10","doi-asserted-by":"crossref","unstructured":"Faivre-Finn C, Edwards JG, Hatton M. Postoperative radiation therapy should not be used for the therapy of stage III-N2 NSCLC. 17, J Thorac Oncol. 2022.","DOI":"10.1016\/j.jtho.2021.09.005"},{"key":"3752_CR11","doi-asserted-by":"crossref","unstructured":"Erol C, Hizal M, Kahraman S, Bardakci M, Sener Dede D, Bulent Akinci M et al. Are the clinical trials in lung cancer an advantage for patients in developing countries? 2024.","DOI":"10.1200\/JCO.2024.42.16_suppl.e20523"},{"key":"3752_CR12","doi-asserted-by":"crossref","unstructured":"Guo L, Zhu C, Cai L, Zhang X, Fang Y, Chen H et al. Global burden of lung cancer in 2022 and projected burden in 2050. Chin Med J (Engl). 2024.","DOI":"10.1097\/CM9.0000000000003268"},{"key":"3752_CR13","doi-asserted-by":"crossref","unstructured":"Sekine Y, Behnia M, Fujisawa T. Impact of COPD on pulmonary complications and on long-term survival of patients undergoing surgery for NSCLC. In: Lung Cancer. 2002.","DOI":"10.1016\/S0169-5002(02)00014-4"},{"key":"3752_CR14","doi-asserted-by":"crossref","unstructured":"Leshem Y, Dolev Y, Siegelmann-Danieli N, Sharman Moser S, Apter L, Chodick G et al. Association between diabetes mellitus and reduced efficacy of pembrolizumab in non\u2013small cell lung cancer. Cancer. 2023;129(18).","DOI":"10.1002\/cncr.34918"},{"key":"3752_CR15","unstructured":"Cortellini A, D\u2019Alessio A, Cleary S, Buti S, Bersanelli M, Bordi P et al. Type 2 diabetes mellitus and efficacy outcomes from immune checkpoint Blockade in patients with cancer. Clin Cancer Res. 2023;29(14)."},{"key":"3752_CR16","doi-asserted-by":"crossref","unstructured":"Vu N, Tien Manh D, Viet Cuong N, Hong Son N, Quoc Viet T, Onishi H et al. Long-term survival outcome of radiation therapy for unresectable, locally advanced non-small cell lung cancer: Single center experience at Hospital 175. 2024.","DOI":"10.1200\/GO.2023.9.Supplement_1.142"},{"key":"3752_CR17","doi-asserted-by":"crossref","unstructured":"Suaiti L, Sullivan TB, Rieger-Christ KM, Servais EL, Suzuki K, Burks EJ. Vascular invasion predicts recurrence in stage IA2-IB lung adenocarcinoma but not squamous cell carcinoma. Clin Lung Cancer. 2023;24(3).","DOI":"10.1016\/j.cllc.2022.12.006"},{"key":"3752_CR18","doi-asserted-by":"crossref","unstructured":"Huang X, Feng Y, Li Y, Ding H, Huang X, Chen C et al. A novel transcriptomic signature associated with lymphovascular invasion predicts clinical outcomes, tumor microenvironment, and therapeutic response in lung adenocarcinoma. Int Immunopharmacol. 2024;127.","DOI":"10.1016\/j.intimp.2023.111286"},{"key":"3752_CR19","doi-asserted-by":"crossref","unstructured":"Zuo Z, Fan X, Tang Y, Zhang Y, Peng X, Zeng W et al. Deep learning-powered 3D segmentation derives factors associated with lymphovascular invasion and prognosis in clinical T1 stage non-small cell lung cancer. Heliyon. 2023;9(4).","DOI":"10.1016\/j.heliyon.2023.e15147"},{"key":"3752_CR20","doi-asserted-by":"crossref","unstructured":"Furrer K, Weder W, Eboulet EI, Betticher D, Pless M, Stupp R et al. Extended resection for potentially operable patients with stage III non\u2013small cell lung cancer after induction treatment. In: J Thorac Cardiovasc Surg. 2022.","DOI":"10.1016\/j.jtcvs.2022.03.034"},{"key":"3752_CR21","doi-asserted-by":"crossref","unstructured":"Werner RS, Furrer K, Lauk O, Caviezel C, Hillinger S, Schneiter D et al. Salvage surgery in patients with locally advanced or metastatic Non-Small cell lung cancer. Br J Surg. 2023;110(Supplement_5).","DOI":"10.1093\/bjs\/znad178.056"},{"key":"3752_CR22","doi-asserted-by":"crossref","unstructured":"Hireche K, Lounes Y, Bacri C, Solovei L, Marty-An\u00e9 C, Canaud L et al. VATS versus open lobectomy following induction therapy for stage III NSCLC: A propensity Score-Matched analysis. Cancers (Basel). 2023;15(2).","DOI":"10.3390\/cancers15020414"},{"key":"3752_CR23","doi-asserted-by":"crossref","unstructured":"Cao J, Zhang C, Zhang X, Liu L, Li X, He J et al. The clinical outcomes of thoracoscopic versus open lobectomy for Non\u2013Small-Cell lung cancer after neoadjuvant therapy: A Multi-Center retrospective cohort study. Clin Lung Cancer. 2024;25(3).","DOI":"10.1016\/j.cllc.2023.12.008"},{"key":"3752_CR24","doi-asserted-by":"crossref","unstructured":"Kasprzyk M, S\u0142awi\u0144ski G, Musik M, Marciniak \u0141, Dyszkiewicz W, Piwkowski C et al. Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer. Kardiochirurgia I Torakochirurgia Polska. 2015;12(1).","DOI":"10.5114\/kitp.2015.50563"},{"key":"3752_CR25","doi-asserted-by":"crossref","unstructured":"Yang Z, Wang S, Yang H, Jiang Y, Zhu L, Zheng B et al. Treatment patterns and clinical outcomes of patients with resectable non\u2013small cell lung cancer receiving neoadjuvant immunochemotherapy: A large-scale, multicenter, real-world study (NeoR-World). J Thorac Cardiovasc Surg. 2024.","DOI":"10.1016\/j.jtcvs.2024.02.006"},{"key":"3752_CR26","doi-asserted-by":"publisher","unstructured":"Orosz Z, Kov\u00e1cs \u00c1. The role of chemoradiotherapy and immunotherapy in stage III NSCLC. Vol. 30, pathology and oncology research.  Pathol Oncol Res. 2024; 30:1611716. https:\/\/doi.org\/10.3389\/pore.2024.1611716","DOI":"10.3389\/pore.2024.1611716"},{"key":"3752_CR27","doi-asserted-by":"publisher","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM et al. Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer. New England Journal of Medicine [Internet]. 2022 May 26 [cited 2025 Sep 26];386(21):1973\u201385. Available from: https:\/\/www.nejm.org\/doi\/pdf\/https:\/\/doi.org\/10.1056\/NEJMoa2202170","DOI":"10.1056\/NEJMoa2202170"},{"key":"3752_CR28","doi-asserted-by":"publisher","unstructured":"Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S et al. Perioperative Pembrolizumab for Early-Stage Non\u2013Small-Cell Lung Cancer. New England Journal of Medicine [Internet]. 2023 Aug 10 [cited 2025 Sep 26];389(6):491\u2013503. Available from: https:\/\/www.nejm.org\/doi\/pdf\/https:\/\/doi.org\/10.1056\/NEJMoa2302983","DOI":"10.1056\/NEJMoa2302983"},{"key":"3752_CR29","doi-asserted-by":"crossref","unstructured":"K\u00e4smann L, Eze C, Taugner J, Roengvoraphoj O, Dantes M, Schmidt-Hegemann NS et al. Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials Establishing a novel multimodal strategy. 15, Radiat Oncol. 2020.","DOI":"10.1186\/s13014-020-01595-3"},{"key":"3752_CR30","doi-asserted-by":"crossref","unstructured":"Solodkiy VA, Sotnikov VM, Trotsenko SD, Kharchenko VP, Chkhikvadze VD, Nudnov NV et al. Non-small cell lung cancer recurrences after surgical and combined modality treatment with postoperative radiation therapy. Med Radiol Radiation Saf. 2018;63(6).","DOI":"10.12737\/article_5c0b90d10ff212.78053112"},{"key":"3752_CR31","doi-asserted-by":"crossref","unstructured":"Manapov F, Nieto A, K\u00e4smann L, Taugner J, Kenndoff S, Fl\u00f6rsch B et al. Five years after PACIFIC: update on multimodal treatment efficacy based on real-world reports. Expert Opin Investig Drugs 2023;32(3).","DOI":"10.1080\/13543784.2023.2179479"},{"key":"3752_CR32","unstructured":"Katherina C, Chua. Assieh Saadatpour; Ariel Chen; Aisha Hasan; Bevan Emma Huang; Stewart Bates. Evaluating biomarkers of immunotherapy response in a real-world metastatic NSCLC cohort. Cancer Res. 2024."},{"key":"3752_CR33","doi-asserted-by":"crossref","unstructured":"Konert T, Vogel WV, Paez D, Polo A, Fidarova E, Carvalho H et al. Introducing FDG PET\/CT-guided chemoradiotherapy for stage III NSCLC in low- and middle-income countries: preliminary results from the IAEA PERTAIN trial. Eur J Nucl Med Mol Imaging. 2019;46(11).","DOI":"10.1007\/s00259-019-04421-5"},{"key":"3752_CR34","doi-asserted-by":"crossref","unstructured":"Jiwnani S, Penumadu P, Ashok A, Pramesh CS. Lung Cancer Management in Low and Middle-Income Countries. Vol. 32, Thoracic surgery clinics. 2022.","DOI":"10.1016\/j.thorsurg.2022.04.005"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03752-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03752-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03752-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T20:57:07Z","timestamp":1767041827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-025-03752-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3752"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03752-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6302087\/v1","asserted-by":"object"}]},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local Ethics Committee of the KHCC on August 29th, 2021 (Proposal No. 21 KHCC 115). The need for informed consent was waived due to the retrospective analysis of routinely collected patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"473"}}